PSY67 REASONS FOR INITIATING INTRAVENOUS BIOLOGIC THERAPY AMONG PATIENTS WITH IMMUNOLOGY CONDITIONS- SUBSET ANALYSIS OF PRIOR SUBCUTANEOUS INJECTION (SQ) USERS AND IMPLICATIONS FOR SHARED DECISION MAKING
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.399
https://www.valueinhealthjournal.com/article/S1098-3015(11)00538-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
961
First Page :
A71
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00538-9&doi=10.1016/j.jval.2011.02.399